Tesamorelin and Sermorelin are both growth-hormone-releasing peptide 1 (GHRP-1) analogues, but they serve different purposes and act with somewhat different intensities
While your body produces it naturally, levels decline with age, stress, and environmental toxin exposure
And looks just like the real thing!
Competition from Alternative Therapies: The GLP-1 Receptor Agonist Market is characterized by intense competition from alternative therapies, including SGLT-2 inhibitors and basal insulin treatments
Hansen JM, Go YM, Jones DP
For uninsured patients or those with high deductibles, compounded GLP-1 provides immediate, affordable access to evidence-based weight loss treatment